These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36365030)

  • 1. Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis.
    Yoneda R; Iinuma T; Sakurai D; Kurita J; Arai T; Sonobe Y; Yonekura S; Okamoto Y; Hanazawa T
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status.
    Sakurai D; Ishii H; Shimamura A; Watanabe D; Yonaga T; Matsuoka T
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary Clinical Trial of Biomarkers to Predict Response to Sublingual Immunotherapy for Japanese Cedar Pollinosis.
    Takahara E; Matsune S; Ishida M; Wakayama N; Okubo K
    J Nippon Med Sch; 2020 Dec; 87(5):277-284. PubMed ID: 32074537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
    Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
    Otsuka K; Otsuka H; Matsune S; Okubo K
    Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Takeda N
    J Med Invest; 2022; 69(1.2):97-100. PubMed ID: 35466153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic T
    Iinuma T; Kiuchi M; Hirahara K; Kurita J; Kokubo K; Yagyu H; Yoneda R; Arai T; Sonobe Y; Fukuyo M; Kaneda A; Yonekura S; Nakayama T; Okamoto Y; Hanazawa T
    J Allergy Clin Immunol; 2022 Oct; 150(4):850-860.e5. PubMed ID: 35863510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
    Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.
    Yang Y; Zhou W; Chen A
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):348-353. PubMed ID: 27566862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE
    Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
    Arerugi; 2020; 69(9):909-917. PubMed ID: 33191379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis].
    Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
    Nihon Jibiinkoka Gakkai Kaiho; 2016 Dec; 119(12):1504-10. PubMed ID: 30035481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
    Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
    Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
    Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.